Replies to post #210938 on Biotech Values

[DewDiligence]

Demystifying AZN’s MYSTIC trial in first-line NSCLC (@JacobPlieth):

http://epvantage.com/Universal/View.aspx?type=Story&id=717402&isEPVantage=yes

There are a lot of permutations here!